World J Gastrointest Surg. 2010 April 27; 2(4): 147-152.
Published online 2010 April 27. doi: 10.4240/wjgs.v2.i4.147.
©2010 Baishideng. All rights reserved.
Laparoscopic splenectomy for splenic hamartoma: Case management and clinical consequences
Tsutomu Namikawa, Hiroyuki Kitagawa, Jun Iwabu, Kazuhiro Hanazaki, Department of Surgery, Kochi Medical School, Kohasu-Okocho, Nankoku, Kochi 783-8505, Japan
Michiya Kobayashi, Department of Human Health and Medical Sciences, Kochi Medical School, Kohasu-Okocho, Nankoku, Kochi 783-8505, Japan
Manabu Matsumoto, Laboratory of Diagnostic Pathology, Kochi Medical School, Kohasu-Okocho, Nankoku, Kochi 783-8505, Japan
Received November 13, 2009; Revised January 11, 2010; Accepted January 18, 2010;
Splenic hamartoma is a rare benign tumor, and although minimally invasive surgery may be suitable for this condition, there have only been 2 previous reports of laparoscopic surgery. Here we report the third case of splenic hamartoma managed by laparoscopic splenectomy. A 37-year-old male was incidentally diagnosed by abdominal ultrasonography with a hypoechoic mass measuring 2.5 cm × 2.4 cm in the spleen. Color Doppler sonography showed multiple flow signals within the mass and contrast-enhanced computed tomography revealed strong enhancement of the lesion. On T1- and T2-weighted magnetic resonance images, the splenic mass was demonstrated as isointense and hyperintense respectively. Although a malignant tumor could not be ruled out, a hand-assisted laparoscopic splenectomy was performed because the splenic mass was limited in size and had not invaded adjacent organs. The pathological diagnosis was splenic hamartoma. The postoperative course was uneventful and the patient was discharged by the seventh postoperative day. Although splenic hamartomas have some specific imaging features, more reports and analyses of these cases are required to increase the reliability of the diagnosis and management. Hand-assisted laparoscopic splenectomy may play a pivotal role in the postoperative diagnosis and management of this condition.
Keywords: Splenic hamartoma, Splenoma, Splenic tumor, Laparoscopic splenectomy, Splenectomy
Splenic tumors are relatively uncommon. Among them, lymphomatous tumors of the spleen are the most common with other tumors including angiosarcomas, plasmacytomas, primary malignant fibrous histiocytomas, and metastatic disease to the spleen often associated with diffuse carcinomatous dissemination. Benign splenic tumors are exceedingly rare with an incidence of 7 in 100000 autopsy specimens[1
] and most are either cysts or hemangiomas.
Splenic hamartoma is an extremely rare benign tumor with an incidence of 3 in 200000 splenectomies[2
]. Although splenic hamartomas are benign and usually asymptomatic[2
], it is important that they are not mistaken for malignant lesions which can sometimes occur due to diagnostic difficulties. Splenectomy has traditionally been performed through a generous laparotomy incision, requiring complete mobilization of the spleen for removal. Recently, laparoscopic surgery has become the standard technique for the surgical treatment of many disorders including malignant diseases. Although minimally invasive surgery may be suitable for splenic hamartomas, to the best of our knowledge, there have been only 2 previous reports of laparoscopic surgery for splenic hamartoma. Here we report a third case of splenic hamartoma that underwent laparoscopic splenectomy.
A 37-year-old Japanese male was incidentally diagnosed with a splenic mass by abdominal ultrasonography (US) and visited our hospital for further investigation. On physical examination, he was afebrile with normal vital signs and no weight loss. The laboratory findings on admission were unremarkable: red blood cell count 460 × 104/mm3 (normal range 370-490 × 104/mm3); white blood cell count 4.7 × 103/mm3 (normal range 4.0-8.0 × 103/mm3); and platelet count 25.3 × 104/mm3 (normal range 14.5-34.0 × 104/mm3). Total protein, alanine aminotransferase, aspartate aminotransferase, total bilirubin and serum creatinine levels were all within normal limits, as were serum carcinoembryonic antigen and cancer antigen 19-9.
Abdominal US showed a distinct, round and hypoechoic mass measuring 2.5 cm × 2.4 cm in the spleen (Figure ). Color Doppler sonography showed blood flow signals along the edge of the mass and slight signals within the mass (Figure ). Computed tomography (CT) images before the administration of contrast material showed a slightly hypodense lesion relative to the normal splenic parenchyma, measuring 2.4 cm × 2.3 cm within the spleen (Figure ). Following a bolus injection of intravenous contrast material, the mass was strongly enhanced during the early and late hepatic artery phase (Figure ) and 3 min after the administration of contrast, the mass showed isodensity. The lesion was a homogenous mass with no calcification or cystic lesions observed. Magnetic resonance imaging (MRI) showed isointensity in the T1-weighted image and heterogeneous hyperintensity in the T2-weighted image (Figure ). The lesion showed diffuse enhancement on gadolinium-enhanced MRI. Positron emission tomography (PET) using 18F-fluoro-2-deoxy-d-glucose (FDG) with CT showed no abnormal accumulation of FDG. Esophagogastroduodenoscopy and colonoscopy showed no significant lesion.
Ultrasonography and computed tomography (CT) of the splenic lesion. A: Gray-scale ultrasonography shows a homogenous and hypoechoic mass at the mid-portion of the spleen; B: Color Doppler sonography shows multiple color circular flow signals within the mass; C: CT shows a slightly lower-density mass in the spleen (arrows); D: The mass demonstrated strong enhancement after the intravenous administration of contrast material.
Magnetic resonance imaging (MRI) of the splenic lesion. A: T1-weighted MRI shows the isointense mass (arrows); B: The mass is mildly hyperintense in the T2-weighted MRI; C: The early phase of dynamic MRI shows diffuse heterogeneous enhancement of the mass; D: The mass becomes more enhanced during the delayed phase.
Although the diagnosis of a malignant tumor was not excluded completely, a hand-assisted laparoscopic splenectomy was performed because the splenic mass was limited in size and had not invaded adjacent organs. The patient was placed on the operating table in a right semilateral decubitus position with the left arm tucked above the head. An incision measuring 7.5 cm, large enough for the surgeon’s hand and forearm, was made in the upper midline of the abdomen and three ports were used. The splenic artery at the tail of the pancreas was double ligated with absorbable suture. After mobilization of the spleen, the splenic vein at the splenic hilum was finally ligated and the resected spleen, contained in a plastic bag, was extracted through the upper midline incision. The total operation time and estimated intraoperative blood loss were 100 min and 20 mL respectively. The patient’s postoperative course was uneventful and he was discharged on the seventh postoperative day.
The resected spleen weighed 110 g and measured 8.0 cm× 5.0 cm × 4.5 cm. The mass was noted deep inside the spleen near the hilum. Gross examination of the cut surface showed a dark-red, solid, well-circumscribed and firm lesion measuring 2.5 cm × 2.4 cm × 2.4 cm (Figure ). There were no cystic lesions within the tumor.
Macroscopic appearance of the resected spleen showing a circumscribed mass measuring 2.5 cm × 2.4 cm in diameter (arrows).
Microscopically, the splenic tumor showed expansive growth, compressing the surrounding splenic tissue without a capsule. The tumor consisted of disorganized vascular channels lined by slightly plump endothelial cells without atypia, mixed with intervening splenic red pulp-like stroma without fibrous trabeculae and white pulp (Figure ). Immunohistochemical staining was performed and the endothelial cells that lined the vascular channels stained positive for CD8 indicating splenic type endothelium, but negative for CD34 which detects the intervening cord capillaries (Figure ). The pathological diagnosis was splenic hamartoma.
Pathology of the splenic lesion. A: Microscopically, the mass is composed of predominantly a red pulp splenic sinusoidal structure accompanied by lymphocytes and macrophages. Atypical cells or mitosis were not observed; B: The endothelial cells lining the sinusoidal structure are immunoreactive for CD8.
Splenic hamartoma is a rare benign tumor with vascular proliferation which is usually diagnosed pathologically after laparotomy, splenectomy or at autopsy[1,2
]. The pathogenesis of splenic hamartoma varies and includes congenital malformation of the splenic red pulp, neoplasia or a reactive lesion to prior trauma[2,3
]. Splenic hamartoma is often called splenoma or nodular hyperplasia because it is composed of an aberrant mixture of the normal tissue components of the spleen[4
]. As the majority of patients are asymptomatic, most splenic hamartomas are found incidentally by modern imaging methods including US or CT scans[3,4
], as in this case.
Recent advances in imaging modalities have improved the ability to detect asymptomatic splenic masses[5,6
]. However, the differential diagnosis at imaging in respect to more frequent focal lesions of the spleen is still not straightforward. Although splenic hamartoma should be considered as a differential diagnosis for all splenic masses, it is important to distinguish splenic hamartomas from splenic hemangiomas, the most common benign splenic tumor. Table shows some of the differences observed in the US, CT and MRI findings of splenic hamartomas compared to splenic hemangiomas.
Imaging comparisons between splenic hamartoma and splenic hemangioma
The macroscopic type of splenic hemangioma determines the US findings - a capillary hemangioma appears as a hyperechoic nodule whereas a cavernous hemangioma is seen as a heterogeneous hypoechoic mass, sometimes with calcification or multiple cystic areas[6
]. Generally, splenic hamartomas have been described as solid, homogenous masses with various echogenic patterns relative to the normal splenic parenchyma, showing usually a hypoechoic, but occasionally hyperechoic lesion with or without cystic changes in the spleen[3,4,7
]. The color Doppler sonograms of splenic hemangiomas show only a few color echoes which can appear in the tumor immediately after it is compressed by the probe[8
]. On the other hand, the color Doppler sonographic findings in splenic hamartomas are multiple radial blood-flow signals inside the mass[9
]. However, masses inside the spleen are usually less vascular than the surrounding normal parenchyma because of the high vascularity of the spleen. Chou et al[10
] demonstrated that the tumor could be markedly enhanced on color Doppler sonography by the administration of microbubble contrast agents. Thus, US may be an indispensable method for the diagnosis of splenic hamartoma[7
CT scans demonstrate that splenic hamartomas are isodense or hypodense masses and show a dense spreading and prolonged enhancement after intravenous administration of contrast material[11
]. T2-weighted MRI shows most splenic hamartomas as heterogeneously hyperintense lesions relative to the spleen and demonstrates diffuse heterogeneous enhancement on early postcontrast images and more uniform enhancement on delayed images[5,6,12
]. Similar findings were noted in our present case. In the case of splenic hemangiomas, dynamic enhanced imaging using either CT or MRI demonstrates a progressive centripetal pattern of enhancement with prolonged uniform enhancement on delayed images[6,12,13
]. In addition, the fusion of images from FDG-PET with those of CT becomes an important tool in assessing patients with a malignant disease or suspected lymphoma to evaluate other malignant sites[14
]. Avila et al[15
] first reported the findings of PET-CT in splenic hamartomas which demonstrated a moderate FDG avidity, while our current case showed no abnormal accumulation of FDG.
Although there are some specific imaging features of splenic hamartomas, it is difficult to rule out the possibility of a malignant neoplasm based on such imaging studies. The diagnosis must be confirmed by pathological examination. Although there have been some studies about the efficacy and safety of fine needle aspiration biopsy of the spleen, the possibility of bleeding or tumor dissemination makes this technique problematic[16,17
]. Therefore, splenectomy is still necessary for diagnostic and therapeutic purposes. Recently, less invasive treatments have been developed such as laparoscopy-assisted surgery.
The main pathological differential diagnosis for splenic hamartoma is a benign vascular tumor including hemangioma. They also have similar clinical and radiological findings. Immunohistochemical staining can be used to distinguish a splenic hamartoma from a capillary hemangioma by their respective staining characteristics[18,19
]. Endothelial cells which are positive for CD8 are a key feature that distinguishes a hamartoma from other vascular lesions of the spleen[3,19
]. The endothelial cells of hemangiomas are CD8-negative and CD34-positive, in contrast to the CD8-positive and CD34-negative endothelial cells of splenic hamartomas[18,19
]. The splenic hamartoma has been classified into two histological types: the white pulp type and the red pulp type, according to the tumor components[2
]. The former is composed entirely of lymphoid tissue while the latter is composed of sinuses and is histologically similar to that of the normal red pulp of the spleen. Most reported cases are the red pulp type, including this present report. Multiple flow signals on color Doppler US and strongly enhanced findings on CT and MRI in our case are thought to be a reflection of the characteristic hypervascularity of the red pulp itself.
Laparoscopic splenectomy is the standard surgical procedure for the management of most cases of idiopathic thrombocytopenic purpura because of the lower operative and perioperative morbidity, compared to open splenectomy[20,21
]. Moreover, laparoscopic splenectomy has become the surgical procedure of choice for not only the management of idiopathic thrombocytopenic purpura but also of some splenic tumors[14,21-24
]. To the best of our knowledge, only three cases of laparoscopic splenectomy for splenic hamartoma, including our present case, have been reported in detail (Table )[22,25
]. Hand-assisted laparoscopic surgery allows the surgeon to place one hand into the abdominal cavity, providing a tactile sense and improving the accuracy of manipulation while maintaining the pneumoperitoneum. This facilitates the surgical procedure by allowing identification of dissection planes or the hand to function as a retractor. Moreover, if bleeding occurs, it is easily controlled by compression of the hand on the splenic vascular pedicle or the injury site. In our case, the 7.5 cm incision made in the upper abdominal midline was large enough to allow entry of the surgeon’s hand and forearm. The resected spleen can be easily extracted through this incision without the requirement for an additional incision.
Characteristics of reported cases of splenic hamartoma treated by laparoscopic splenectomy
In conclusion, although there are some imaging features that are specific to splenic hamartomas, the collection and analysis of more of these cases is necessary to improve the reliability of the diagnosis and management of this condition. Hand-assisted laparoscopic splenectomy may play a pivotal role in the postoperative diagnosis and management of splenic hamartomas.
Moriyama S, Inayoshi A, Kurano R. Inflammatory pseudotumor of the spleen: report of a case. Surg Today.
Silverman ML, LiVolsi VA. Splenic hamartoma. Am J Clin Pathol.
Lee H, Maeda K. Hamartoma of the spleen. Arch Pathol Lab Med.
Yu RS, Zhang SZ, Hua JM. Imaging findings of splenic hamartoma. World J Gastroenterol.
Elsayes KM, Narra VR, Mukundan G, Lewis JS Jr, Menias CO, Heiken JP. MR imaging of the spleen: spectrum of abnormalities. Radiographics.
Giovagnoni A, Giorgi C, Goteri G. Tumours of the spleen. Cancer Imaging.
Nakanishi S, Shiraki K, Yamamoto K, Nakano T, Koyama M, Yano T, Sanda T, Tamaki H, Hirano T, Fukudome K. Basket pattern blood flow signals discovered in a case of splenic hamartoma by power Doppler ultrasonography. World J Gastroenterol.
Niizawa M, Ishida H, Morikawa P, Naganuma H, Masamune O. Color Doppler sonography in a case of splenic hemangioma: value of compressing the tumor. AJR Am J Roentgenol.
Tang S, Shimizu T, Kikuchi Y, Shinya S, Kishimoto R, Fujioka Y, Miyasaka K. Color Doppler sonographic findings in splenic hamartoma. J Clin Ultrasound.
Chou YH, Chiou HJ, Tiu CM, Chiou SY, Hsia CY, Tsay SH. Splenic hamartoma: presentation on contrast-enhanced sonography. J Clin Ultrasound.
Ohtomo K, Fukuda H, Mori K, Minami M, Itai Y, Inoue Y. CT and MR appearances of splenic hamartoma. J Comput Assist Tomogr.
Ramani M, Reinhold C, Semelka RC, Siegelman ES, Liang L, Ascher SM, Brown JJ, Eisen RN, Bret PM. Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions. Radiology.
Fujii T, Obara T, Shudo R, Tanno S, Maguchi H, Saitoh Y, Ura H, Kohgo Y. Splenic hamartoma associated with thrombocytopenia. J Gastroenterol.
Makrin V, Avital S, White I, Sagie B, Szold A. Laparoscopic splenectomy for solitary splenic tumors. Surg Endosc.
Avila L, Sivaprakasam P, Viero S, Somers GR, Shago M, Gerstle JT, Metser U, Gupta AA. Splenic hamartoma in a child in the era of PET-CT. Pediatr Blood Cancer.
Conlon S, Royston D, Murphy P. Splenic hamartoma. Cytopathology.
Caraway NP, Fanning CV. Use of fine-needle aspiration biopsy in the evaluation of splenic lesions in a cancer center. Diagn Cytopathol.
Falk S, Stutte HJ. Hamartomas of the spleen: a study of 20 biopsy cases. Histopathology.
Zukerberg LR, Kaynor BL, Silverman ML, Harris NL. Splenic hamartoma and capillary hemangioma are distinct entities: immunohistochemical analysis of CD8 expression by endothelial cells. Hum Pathol.
Sampath S, Meneghetti AT, MacFarlane JK, Nguyen NH, Benny WB, Panton ON.An 18-year review of open and laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Am J Surg.
:580-583; discussion 583-584.[PubMed] [DOI]
Habermalz B, Sauerland S, Decker G, Delaitre B, Gigot JF, Leandros E, Lechner K, Rhodes M, Silecchia G, Szold A. Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc.
Tatekawa Y, Kanehiro H, Nakajima Y. Laparoscopic extirpation of splenic hamartoma. Pediatr Surg Int.
Uranues S, Grossman D, Ludwig L, Bergamaschi R. Laparoscopic partial splenectomy. Surg Endosc.
Tessier DJ, Pierce RA, Brunt LM, Halpin VJ, Eagon JC, Frisella MM, Czerniejewski S, Matthews BD. Laparoscopic splenectomy for splenic masses. Surg Endosc.
Yoshizumi T, Iso Y, Yasunaga C, Kitano S, Sugimachi K. Laparoscopic splenectomy for splenic hamartoma. Surg Endosc.